🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

For those living with #IBS, our online #meditation and #yoga program starts October 6th. If you are interested, or know someone who may be, please reach out or check out our study website. cumming.ucalgary.ca/research/ascen…

For anyone looking for help with #scientificwriting, I highly recommend edgewriting.ca. Get your #publication over the finish line!

A list of super useful resources for academics, especially graduate students (…to make our lives just a tad easier 😅)

Check this paper out if you’re doing #microbiome research! There are now reporting guidelines you can use for your publications.

Dr. Maitreyi Raman Snyder Institute for Chronic Diseases member was awarded the 2021 Outstanding Researcher, Women in IBD Awards by Crohn's and Colitis Canada, & Pfizer Canada, for her valuable contributions as outstanding female leader in IBD research. Congrats Dr. Raman! bit.ly/3DVkvFM #IBD #Crohns

‼️ 1 in 2 IBD patients has fatigue CGH Danielle Fox @yasipasi Full article: cghjournal.org/article/s1542-…

For those living with #IBS, please consider helping with our research study: blog.katescarlata.com/2022/05/09/ple… PLEASE RT!

Today was a big day for me. I became Dr. D’Silva!!! Thank you to @yasipasi Dr. Deborah A Marshall Research Team Dr. Bala Subramaniam Sonia Butalia, MD FRCPC MSc Dr. Jeff Vallance & Dr. Maitreyi Raman!

📢 New article from #JCAG Journal of the Canadian Assn of Gastroenterology 📰 Gastroenterologist and Patient Attitudes Toward Yoga as a Therapy for #IBS: An Application of the Theory of Planned Behaviour 🧘 ✍️ Adrijana D'Silva Dr. Deborah A Marshall Research Team @yasipasi and peers! 🔗 buff.ly/3Bcm6XC

Our study is out! #IBS has three main microtypes. H2S gas (Desulfovibrio & Fusobacteria) drives diarrhea, H2 producers (E. coli & Klebsiella) driving SIBO type, and Methanobrevibacter (CH4) driving constipation. Forms the basis for new treatments coming. journals.lww.com/ajg/Abstract/9…

Meta-analysis of fecal microbiota transplantation in irritable bowel syndrome finds no benefit for symptom severity. #MedTwitter #GITwitter #IBS #microbiome #FMT #DGBI #FGID onlinelibrary.wiley.com/doi/full/10.10…

Signed 🤞

7 subtypes of irritable bowel syndrome identified: 🩺perceived health impairment 1️⃣moderate 2️⃣severe 🧠psychoneurological factors 3️⃣⬆️Ψ/neuro 4️⃣⬆️Ψ 5️⃣⬆️Neuro 💩bowel dysfunction 6️⃣diarrhea 7️⃣constipation #MedTwitter #GITwitter #IBS sciencedirect.com/science/articl…

I'm very happy to announce I was awarded the #CIHR Health System Impact Fellowship, which I started in September with Alberta Health Services and UCalgaryMedicine. I'll be working with some of the most talented scientists to improve the management of #IBS in primary care. CIHR

A new #RapidRCTinAJG - accelerating the time from RCT to publication: Meditation and Yoga for Irritable Bowel Syndrome: A Randomized Clinical Trial by D'Silva, et al. 👉 bit.ly/3UTsA5O Adrijana D'Silva @yasipasi Jasmohan Bajaj Millie Long #RedJournal

Have a digestive disease and need a dietician? LyfeMD and Cdn Digestive Health have partnered to provide folks like you with free dietician support. Check out the link to see if you qualify! #IBD #IBS #celiac lyfemd.practicebetter.io/?fbclid=IwAR06…

📰 Gastroenterologist and Patient Attitudes Toward Yoga as a Therapy for #IBS: An Application of the Theory of Planned Behaviour #JCAG Journal of the Canadian Assn of Gastroenterology ✍️ Adrijana D'Silva Dr. Deborah A Marshall Research Team @yasipasi #JeffVallance #AdrianaLazarescu #MaitreyiRaman 🔗 buff.ly/3Ilow9Z

The IMAGINE Network is looking for a Research Coordinator! More information on our website: lnkd.in/g2v7NWsp

If you can’t make it in-person to today’s Gairdner Symposium, click below to watch the livestream. Welcome remarks from @StelfoxTom, Janet Rossant and @kmfiest start at 8:45. obrieniph.ucalgary.ca/Gairdner-Sympo… Gairdner Foundation

Warm welcome to the new #CIHR_ImpactFellows!